Halozyme Therapeutics reported $74.11M in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -14.79M 28.61M
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Alnylam Pharmaceuticals ALNY:US $ -212.93M 24.6M
Amarin AMRN:US $ -12.97M 21.83M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Baxter International BAX:US $ 608M 107M
Cara Therapeutics CARA:US $ -1013000 29.73M
Cytokinetics CYTK:US $ -76.09M 14.53M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Immunogen IMGN:US $ -37.34M 6.6M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Intra Cellular Therapies ITCI:US $ -76.93M 8.21M
Intrexon XON:US $ -29.88M 9.76M
IONIS PHARMACEUT IONS:US $ -84M 3M
Mannkind MNKD:US $ -4.43M 31.1M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Peregrine Pharmaceuticals PPHM:US $ 6.3M 4.31M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
United Therapeutics UTHR:US $ 204.4M 12.1M
Vanda Pharmaceuticals VNDA:US $ 10.72M 1.88M